Hepsi bir arada: �oklu koroner stent, stent trombozu �yk�s�, pankreatik karsinoma, ameliyat sonras� kanama, trombositoz

Demir, Asl�; Ilhan, Seda; Balc�, Eda; P�nar, O�uzhan; �zg�k, Ay�eg�l

Cilt : 27 Say� : 2 Y�l : 2024

30/12Gelecek Say� Ar�iv Kapaklar Pop�ler Makaleler

ICMJE COI Form

H�zl� Arama

Hepsi bir arada: �oklu koroner stent, stent trombozu �yk�s�, pankreatik karsinoma, ameliyat sonras� kanama, trombositoz [Ulus Travma Acil Cerrahi Derg]

Ulus Travma Acil Cerrahi Derg. 2021; 27(2): 268-270 | DOI: 10.14744/tjtes.2020.81624

Hepsi bir arada: �oklu koroner stent, stent trombozu �yk�s�, pankreatik karsinoma, ameliyat sonras� kanama, trombositoz

Asl� Demir, Seda Ilhan, Eda Balc�, O�uzhan P�nar, Ay�eg�l �zg�k
Ankara �ehir Hastanesi, Anesteziyoloji Klini�i, Ankara

Stenli hastalar�n y�netimi, her ne kadar k�lavuzlarda anlat�lsa da, baz� hastalar benzersiz ve s�n�f d�� olabilir. Bu sunumda, hastan�n perioperatif miyokart hasar�na sebep olabilecek bir�ok trombotik risk fakt�r� vard�r. Bu fakt�rler; �oklu ila� sal�n�ml� stent �yk�s� ile birlikte koroner arter hastal��, stent trombozu �yk�s�, 11 ay �nce yerle�tirilmi� yeni stent ve malignensi ve cerrahi i�leme ba�l� hiperkoag�lopatidir. Hastan�n ila� sal�n�ml� stent �yk�s�, perioperatif kanama ve stent tromboz riskini en aza indirmek i�in en uygun y�ntemi d��nd�rerek anestezi, cerrahi ve kardiyoloji ekipleri i�in bir ikilem olu�turmu�tur.

Anahtar Kelimeler: �kili antiplatelet terapi, ila� sal�n�ml� stent, miyokart infarkt�s�; perioperatif kanama; stent trombozu.

All in one: Multiple coronary stents, history of stent thrombosis, pancreatic carcinoma, postoperative bleeding and thrombocytosis

Asl� Demir, Seda Ilhan, Eda Balc�, O�uzhan P�nar, Ay�eg�l �zg�k
Department of Anesthesiology, Ankara City Hospital, Ankara-Turkey

Although the management of a stent patient may appear in the guidelines, some patients may be unique and out of class. In this presentation, the patient had multiple thrombotic risk factors for perioperative myocardial injury. These factors included coronary artery disease with multiple implantations of drug-eluting stent (DES), stent thrombosis history, implantation of a new stent 11months ago and hypercoagulability (due to malignancy and surgical procedure). The patient�s history of DES presented a dilemma for the anesthesiology, surgery, and cardiology teams in considering the optimal method to minimize the risk of perioperative bleeding and stent re-thrombosis.

Keywords: Drug-eluting stent, dual antiplatelet therapy, myocardial infarction; perioperative bleeding; stent re-thrombosis.

Sorumlu Yazar: Eda Balc�, T�rkiye
Makale Dili: �ngilizce

ATIF KOPYALA

Tam Metin PDF At�f dosyas� indir RIS EndNote BibTex Medlars Procite Reference Manager Yazara e-posta g�nder Benzer makaleler PubMed Google Scholar